Rain Therapeutics Inc

RAIN | $1.21 0.0% 3.7M

(0.0% 1d) (0.0% 1m) (-83.8% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (979.26% volume)
Earnings Calendar: 2024-03-07
Market Cap: $ 33,371,736
https://www.rainthera.com
Sec Filling | Patents | n/a employees

Rain Therapeutics Inc. is a clinical-stage precision oncology company developing therapies that target oncogenic drivers for which it is able to genetically select patients it believes will most likely benefit. This approach includes using a tumor-agnostic strategy to select patients based on their tumors’ underlying genetics rather than histology. Rain’s lead product candidate, RAIN-32 (milademetan, formerly known as DS-3032), is a small molecule, oral inhibitor of MDM2, which is oncogenic in numerous cancers. In addition to RAIN-32, Rain is also developing a preclinical program that is focused on inducing synthetic lethality in cancer cells by inhibiting RAD52.

cancer t-cell genetic ceiling

add to watch list Paper trade email alert is off

Aveanna Healthcare Holdings Inc

AVAH | $2.215 -2.85% -2.93% 98K

Manufacturing

(0.0% 1d) (-7.7% 1m) (117.1% 1y) (0.0% 2d) (0.0% 3d) (-2.6% 7d) (-75.56% volume)
Earnings Calendar: 2023-11-09
Market Cap: $ 426,118,845
https://www.aveanna.com
Sec Filling | Patents | 2021 employees

Based in Atlanta, Georgia, Aveanna is a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations. Aveanna directly addresses the most pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home, the lower cost care setting preferred by patients.

add to watch list Paper trade email alert is off

Bon Natural Life Ltd

BON | $4.2 17.98% 15.24% 120K

Manufacturing

(0.0% 1d) (676.4% 1m) (201.7% 1y) (0.0% 2d) (0.0% 3d) (-9.9% 7d) (-4.3% volume)
Earnings Calendar:
Market Cap: $ 49,302,380
https://www.bnlus.com
Sec Filling | Patents | 2021 employees

Bon Natural Life Limited focuses on the manufacturing of personal care ingredients, such as plant extracted fragrance compounds for perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements by their customers.

add to watch list Paper trade email alert is off

CareMax Inc - Class A

CMAX | $2.505 -14.51% -16.97% 80K

Manufacturing

(0.0% 1d) (-40.2% 1m) (22.1% 1y) (0.0% 2d) (0.0% 3d) (-8.7% 7d) (-61.51% volume)
Earnings Calendar: 2024-03-07
Market Cap: $ 9,526,222
https://www.caremax.com
Sec Filling | Patents | 962 employees

CareMax is a technology-enabled care platform providing value-based care and chronic disease management to seniors. CareMax operates medical centers that offer a comprehensive suite of healthcare and social services, and a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians across the United States.

add to watch list Paper trade email alert is off

High Tide Inc.

HITI | $2.25 0.9% 0.89% 910K

Manufacturing

(0.0% 1d) (39.4% 1m) (74.3% 1y) (0.0% 2d) (0.0% 3d) (-3.7% 7d) (NaN% volume)
Earnings Calendar: 2024-01-29
Market Cap: $ 178,504,801
https://hightideinc.com
Sec Filling | Patents | n/a employees

(CA) High Tide is a retail-focused cannabis company enhanced by the manufacturing and distribution of consumption accessories. The Company is the largest Canadian retailer of recreational cannabis as measured by revenue, with 80 branded retail cannabis locations spanning Ontario, Alberta, Manitoba and Saskatchewan. High Tide's retail segment features the Canna Cabana,KushBar, Meta Cannabis Co., Meta Cannabis Supply Co. and NewLeaf Cannabis banners, with additional locations under development across the country. High Tide has been serving consumers for over a decade through its numerous consumption accessory businesses including e-commerce platforms Grasscity.com and CBDcity.com, and its wholesale distribution division under Valiant Distribution, including the licensed entertainment product manufacturer Famous Brandz. High Tide's strategy as a parent company is to extend and strengthen its integrated value chain, while providing a complete customer experience and maximizing shareholder value.

msa brands

add to watch list Paper trade email alert is off

IM Cannabis Corp

IMCC | $0.611 -15.93% -18.95% 600K

Manufacturing

(0.0% 1d) (208.3% 1m) (34.9% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-62.84% volume)
Earnings Calendar: 2023-11-13
Market Cap: $ 8,181,016
https://imcannabis.com
Sec Filling | Patents | 2020 employees

IMC is an MCO in the medical cannabis sector headquartered in Israel and with operations In Israel and Germany. Over the past decade, the Company believes that the IMC brand has become synonymous with quality and consistency in the Israeli medical cannabis market. The Company has also expanded its business to offer intellectual property-related services to the medical cannabis industry. In Europe, IMC operates through Adjupharm GmbH ("Adjupharm"), a German-based subsidiary and EU-GMP certified medical cannabis distributor. IMC's European presence is augmented by strategic alliances with various pan-European EU-GMP cultivators and distributors to capitalize on the increased demand for medical cannabis products in Europe and bring the IMC brand and its product portfolio to European patients.

israel brands cannabis

add to watch list Paper trade email alert is off

KULR Technology Group Inc

KULR | $0.4801 -4.95% 1.6% 5.4M

Manufacturing

(0.0% 1d) (200.9% 1m) (-35.1% 1y) (0.0% 2d) (-5.0% 3d) (-40.4% 7d) (-31.7% volume)
Earnings Calendar:
Market Cap: $ 82,994,554
https://kulrtechnology.com/
Sec Filling | Patents | 9 employees

(US) KULR Technology Group Inc. develops, manufactures and licenses next-generation carbon fiber thermal management technologies for batteries and electronic systems. Leveraging the company's roots in developing breakthrough cooling solutions for NASA space missions and backed by a strong intellectual property portfolio, KULR enables leading aerospace, electronics, energy storage, 5G infrastructure, and electric vehicle manufacturers to make their products cooler, lighter and safer for the consumer.

electric vehicles energy electronics batteries eletrical vehicles 5g

add to watch list Paper trade email alert is off

NRX Pharmaceuticals Inc

NRXP | News | $4.17 -3.02% -3.12% 91K

Manufacturing

(0.0% 1d) (769.0% 1m) (558.3% 1y) (0.0% 2d) (-2.8% 3d) (-18.4% 7d) (-53.32% volume)
Earnings Calendar: 2023-11-13
Market Cap: $ 399,068,083
https://www.bigrockpartners.com/spac/spac_aboutus.html
Sec Filling | Patents | 2 employees

(US) Big Rock Partners is a blank check company formed for the purpose of entering into a merger, stock exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. Big Rock Partners' management team includes Richard Ackerman, Chairman, President, and Chief Executive Officer, and Bennett Kim, Chief Financial Officer, Chief Investment Officer, Corporate Secretary and Director.

covid treatment vaccine acquisitions zyesami aviptadil blank check

add to watch list Paper trade email alert is off

Nuwellis Inc

NUWE | $0.2789 -16.75% -20.11% 870K

Manufacturing

(0.0% 1d) (-37.9% 1m) (-93.6% 1y) (0.0% 2d) (-16.4% 3d) (-23.3% 7d) (431.14% volume)
Earnings Calendar: 2024-02-27
Market Cap: $ 1,896,922
https://www.nuwellis.com
Sec Filling | Patents | 15027 employees

(US) Nuwellis, Inc. , formally CHF Solutions, is a medical device company dedicated to changing the lives of patients suffering from fluid overload through science, collaboration, and innovation. The Company is focused on developing, manufacturing and commercializing the Aquadex SmartFlow® system for ultrafiltration therapy. Nuwellis is headquartered in Minneapolis, Minn., with a wholly-owned subsidiary in Ireland. The Company has been listed on the Nasdaq Capital Market since February 2012, previously branded as CHF Solutions

brands

add to watch list Paper trade email alert is off

Ondas Holdings Inc

ONDS 4 | $0.8899 -2.71% -2.79% 110K

Manufacturing

(0.0% 1d) (-6.5% 1m) (-10.0% 1y) (0.0% 2d) (-1.6% 3d) (-6.3% 7d) (88.08% volume)
Earnings Calendar: 2024-04-01
Market Cap: $ 58,377,440
https://www.ondas.com
Sec Filling | Patents | 15 employees

(United States) Ondas Holdings Inc., through its wholly owned subsidiary, Ondas Networks Inc., is a developer of private licensed wireless data networks for mission-critical industrial markets. The Company designs and manufactures its multi-patented, Software Defined Radio (SDR) platform for Mission Critical IoT (MC- IoT) applications. Ondas Networks' customer end markets include utilities, oil and gas, transportation, and government entities whose demands span a wide range of mission critical applications that require secure communications over large and diverse geographical areas, many of which are within challenging radio frequency environments. Customers use the Company's SDR technology to deploy their own private licensed broadband wireless networks. The Company also offers mission-critical entities the option of a managed network service. Ondas Networks' SDR technology supports IEEE 802.16s, the new worldwide standard for private licensed wide area industrial networks.

urea communication security

add to watch list Paper trade email alert is off

Viracta Therapeutics Inc

VIRX | $0.912 27.59% 21.62% 190K

Manufacturing

(0.0% 1d) (-6.9% 1m) (-28.8% 1y) (0.0% 2d) (31.5% 3d) (-20.3% 7d) (-23.43% volume)
Earnings Calendar: 2024-03-13
Market Cap: $ 35,816,460
http://www.sunesis.com/
Sec Filling | Patents | 8 employees

(US) Viracta is a precision oncology company targeting virus-associated malignancies. The Company's proprietary investigational drug, nanatinostat, is currently being evaluated in combination with the antiviral agent valganciclovir as an oral combination therapy in a Phase 2 clinical trial for EBV-positive lymphomas. Viracta is pursuing application of this inducible synthetic lethality approach in other EBV-associated malignancies, such as nasopharyngeal carcinoma, gastric carcinoma, and other virus-related cancers.

cancer antiviral

add to watch list Paper trade email alert is off

Tempest Therapeutics Inc

TPST | $3.26 -2.69% -2.76% 350K

Manufacturing

(0.0% 1d) (-12.6% 1m) (39.1% 1y) (0.0% 2d) (-2.4% 3d) (-8.9% 7d) (44.61% volume)
Earnings Calendar: 2024-03-20
Market Cap: $ 72,346,005
https://www.millendo.com
Sec Filling | Patents | n/a employees

(United States) Millendo Therapeutics is a clinical-stage biopharmaceutical company primarily focused on developing novel treatments for endocrine diseases where current therapies do not exist or are insufficient. Millendo seeks to create distinct and transformative treatments where there is a significant unmet medical need.

endocrine treatment

add to watch list Paper trade email alert is off